Web-economic-crisis-health-systems-and-health-web

Web-economic-crisis-health-systems-and-health-web Web-economic-crisis-health-systems-and-health-web

dracinthiagep
from dracinthiagep More from this publisher
18.06.2015 Views

Kazakhstan Ninel Kadyrova and Tata Chanturidze Economic trends • Although real per capita GDP growth slowed in 2008 and was slightly negative in 2009, Kazakhstan has been largely unaffected by the crisis. • Against the European trend, the unemployment rate has been decreasing. • Total government spending on health is among the lowest in the European region although there was a government budget surplus in every year of the 2008 to 2011 period. Public per capita health spending, which had grown every year with the exception of 2007, decreased slightly in 2011 (Kazakhstan: Fig. 1). Policy responses Kazakhstan Fig 2 gives the trends in per capita spending on health. Changes to public funding for the health system • Public spending on health more than doubled between 2007 and 2011. Changes to health coverage Population (entitlement) • No response reported. The benefits package • Highly specialized medical services, diagnostic care and screening added to the benefits package (2008–2012). • List of benefit population entitled to outpatient prescription medicines free of charge expanded (2011 onwards). • The essential list of drugs replaced with a formulary system based on cost– effectiveness criteria (2010). User charges • No response reported.

420 Economic crisis, health systems and health in Europe: country experience % Kazakhstan: Fig. 1 Economic and fiscal indicators 2000–2007 and 2008–2011 60 55 50 45 40 35 30 25 20 15 10 5 0 −5 −10 −15 −20 −25 −30 _ _ _ _ ● ● _ _ _ _ _ _ _ _ ● _ ● ● _ _ _ _ ● ● _ _ _ _ _ _ _ ● ● ● _ _ _ _ _ _ _ _ _ _ _ _ _ ● ● _ _ _ ● _ ● _ ● _ _ _ _ _ _ _ _ _ _ ● ● ● ● ● _ _ _ _ _ Year 2000−2007 2008 2009 2010 2011 _ _ _ _ _ _ _ _ _ ● ● ● ● ● _ _ _ _ _ Real GDP per capita growth Deficit/surplus (% GDP) Government spending (% GDP) Government health spending (% total government spending) Notes: Deficit/surplus: World Bank; Other indicators: WHO Health for All. 10−year bond rates Unemployment rate Kazakhstan: Fig. 2 Trends in per capita spending on health, 2000–2011 300 Public spending per capita OOP spending per capita Non−OOP private spending per capita Per capita spending $, PPP 200 100 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 30 Growth % 20 10 0 −10 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Public spending per capita growth OOP spending per capita growth Note: Spending calculated from WHO Health for All. Non−OOP private spending per capita growth

Kazakhstan<br />

Ninel Kadyrova <strong>and</strong> Tata Chanturidze<br />

Economic trends<br />

• Although real per capita GDP growth slowed in 2008 <strong>and</strong> was slightly<br />

negative in 2009, Kazakhstan has been largely unaffected by the <strong>crisis</strong>.<br />

• Against the European trend, the unemployment rate has been decreasing.<br />

• Total government spending on <strong>health</strong> is among the lowest in the European<br />

region although there was a government budget surplus in every year of<br />

the 2008 to 2011 period. Public per capita <strong>health</strong> spending, which had<br />

grown every year with the exception of 2007, decreased slightly in 2011<br />

(Kazakhstan: Fig. 1).<br />

Policy responses<br />

Kazakhstan Fig 2 gives the trends in per capita spending on <strong>health</strong>.<br />

Changes to public funding for the <strong>health</strong> system<br />

• Public spending on <strong>health</strong> more than doubled between 2007 <strong>and</strong> 2011.<br />

Changes to <strong>health</strong> coverage<br />

Population (entitlement)<br />

• No response reported.<br />

The benefits package<br />

• Highly specialized medical services, diagnostic care <strong>and</strong> screening added to<br />

the benefits package (2008–2012).<br />

• List of benefit population entitled to outpatient prescription medicines free of<br />

charge exp<strong>and</strong>ed (2011 onwards).<br />

• The essential list of drugs replaced with a formulary system based on cost–<br />

effectiveness criteria (2010).<br />

User charges<br />

• No response reported.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!